Jul 18, 2024 | Cancer Center News
CCIL program leader Brendan Harley was featured on WCIA for Glioblastoma Awareness Day. Researchers worldwide are working to better understand the aggessive brain tumor so they can find new ways to help patients. Watch the interview to hear from Harley about his...
Jul 16, 2024 | Cancer Center News
It was the early 1980s. At the time, glioblastoma patients survived on average for only 10-11 months. Four decades later, the life expectancy has only marginally improved by a few months. For one team of scientists, these aren’t just statistics but family...
Apr 29, 2024 | Cancer Center News
The Cancer Center at Illinois (CCIL) provided an opportunity for students to share their research during its annual Undergraduate Research Symposium at the Beckman Institute. Students in CCIL programs or working in CCIL member labs presented posters on topics...
Jan 24, 2024 | Cancer Center News
University of Illinois Urbana-Champaign research team, from left, Kim Selting, Sara Pedron-Haba, and Catherine Best-Popescu, are recipients of grants from the Cancer Center at Illinois (CCIL) and the Elsa U. Pardee Foundation A $25,000 grant from the Cancer Center at...
Nov 1, 2023 | Cancer Center News
(From left) Brendan Harley, Rex Gaskins, Andrew Steelman, and Payton Haak studied the role of the mitochondrial protein CHCHD2 in glioblastoma Glioblastoma is the most common type of brain tumor that affects adults and, unfortunately, still remains incurable. In a new...
Oct 25, 2022 | Cancer Center News
Glioblastoma spheroid vasculature. Urbana, Ill. – Glioblastoma is the most common and lethal form of primary brain cancer. One of the reasons it is so hard to treat is that it spreads rapidly and diffusely throughout the brain, using structural features such as blood...
Oct 6, 2021 | Cancer Center News
Photo of Sara Pedron Haba. Urbana, Ill. – Many Cancer Center at Illinois (CCIL) researchers have been focusing on glioblastomas, a type of brain cancer that is very aggressive, invasive, and incurable. Sara Pedron Haba, a research assistant professor in chemical and...
Feb 23, 2021 | Cancer Center News
Left – Individual cells invade away from a central tumor spheroid and into the surrounding vascularized microenvironment. Tumor cells are shown in red and vasculature is shown in green. Right – Individual tumor cells (red) interact closely with surrounding vasculature...
Feb 8, 2021 | Cancer Center News
In 2019, Hua Li, research associate professor of bioengineering, was awarded more than $2M from the National Cancer Institute (NCI) shortly after joining the University of Illinois. Since receiving the NCI funds, Li, also a clinical medical physicist at Carle...
Nov 19, 2020 | Cancer Center News
ILLINOIS — A desire to improve the status of cancer patient treatments led former theoretical physicist, Jun Song (PhD), to pivot his career towards cancer research. He spent several years learning about cancer biology and retraining to apply his background in...
Jul 16, 2020 | Cancer Center News
Brendan Harley, CCIL Research Program Leader and Professor of Chemical and Biomolecular Engineering, is studying glioblastoma, an aggressive form of brain cancer. In collaboration with other researchers, Harley’s lab is developing platforms to help scientists...
Mar 12, 2020 | Cancer Center News
Brendan Harley, Professor of Chemical and Biomolecular Engineering and CCIL Program Leader, is studying neurodegenerative disease models with the Director’s Innovation Fund and further support from the NCI. The DIF was initiated by alumnus Scott Fisher to honor...
